Volume 25, Number 7—July 2019
Research Letter
Elizabethkingia bruuniana Infections in Humans, Taiwan, 2005–2017
Table
MIC, mg/L† | ||||||
---|---|---|---|---|---|---|
Piperacillin | 64 | 64 | >64 | 64 | >64 | 64 |
TZP | 32/4 | >128/4 | 32/4 | 32/4 | 64/4 | 128/4 |
Ceftazidime | >16 | >16 | >16 | >16 | >16 | >16 |
Cefepime | >32 | >32 | >32 | >32 | >32 | >32 |
Ceftriaxone | >32 | >32 | >32 | >32 | >32 | >32 |
Aztreonam | >16 | >16 | >16 | >16 | >16 | >16 |
Imipenem | >8 | >8 | >8 | >8 | >8 | >8 |
Meropenem | >8 | >8 | >8 | >8 | >8 | >8 |
Gentamicin | 8 | 8 | 4 | 8 | 4 | 8 |
Tobramycin | >8 | >8 | >8 | >8 | >8 | >8 |
Amikacin | <8 | 32 | 16 | >32 | 16 | 32 |
Tetracycline | >8 | >8 | >8 | >8 | >8 | >8 |
Minocycline | <1 | <1 | <1 | 4 | <1 | <1 |
Tigecycline | <1 | 8 | 2 | 4 | <1 | <1 |
Ciprofloxacin | 1 | 2 | 2 | >2 | 2 | 1 |
Levofloxacin | <1 | 8 | <1 | >8 | <1 | <1 |
TMP/SMX | >4/76 | >4/76 | >4/76 | >4/76 | >4/76 | >4/76 |
*BAL, bronchoalveolar lavage; CHF, congestive heart failure; CVC, central venous catheter; TMP/SMX, trimethoprim/sulfamethoxazole; TZP, piperacillin/tazobactam.
†Light gray shading indicates intermediate susceptibility; dark gray, susceptible isolates; no shading, resistant isolates.
Page created: June 17, 2019
Page updated: June 17, 2019
Page reviewed: June 17, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.